+384.2%
NVDA vs GH
+367.9%
+16.4%
-36.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | GH | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.4% | -2.3% | -0.1% | -2.1% |
| 7D | -4.4% | -1.2% | -3.2% | -4.2% |
| 30D | +0.4% | -3.7% | +4.1% | +0.8% |
| 3M | +9.0% | +21.7% | -12.7% | +5.4% |
| 6M | +18.3% | +75.7% | -57.4% | +8.1% |
| YTD | +17.2% | +55.7% | -38.5% | +8.6% |
| 1Y | +23.3% | +181.1% | -157.8% | +3.7% |
| All | +384.2% | +367.9% | +16.4% | +283.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GH.
Daily Out/Under-Performance
Portfolio return minus GH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded GH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling